Market Overview:
The global meningitis diagnostic testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of meningitis, rising demand for advanced diagnostic tests, and growing awareness about meningitis. Based on type, the latex agglutination tests segment is expected to account for the largest share of the global meningitis diagnostic testing market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030. The large share and high growth rate are attributed to the increasing demand for latex agglutination tests due their accuracy and speed in detecting bacterial antigens associated with meningitis infections. Based on application, hospitals and clinics are expected account for the largest share of the global Menigits Diagnostic Testing Market in 2018 followed by diagnostics centers .
Product Definition:
Meningitis Diagnostic Testing is the process of diagnosing meningitis, a potentially deadly infection of the brain and spinal cord. The tests used to diagnose meningitis include a spinal tap (to collect cerebrospinal fluid for analysis), blood tests, and imaging studies such as CT scans or MRI scans. Meningitis Diagnostic Testing is important because early diagnosis and treatment are essential for preventing serious complications or death.
Latex Agglutination Tests:
Latex agglutination tests are used to detect the presence of antibodies in the blood. These tests are most commonly used for diagnosing meningitis, but they can also be used for other purposes such as testing autoimmune diseases and infectious diseases.
The test works by mixing a small amount of the suspected pathogen with latex and checking whether an agglutinated form is formed after a few hours.
PCR Assay:
Polymerase Chain Reaction (PCR) assay is a technique that uses DNA as a probe to produce multiple copies of specific DNA sequences. The technique is used in molecular diagnostics for the detection and diagnosis of infectious diseases such as HIV, AIDS, cancer, and other viral infections. PCR assay also plays an important role in the diagnosis of various neurological disorders such as brain tumors & epilepsy.
Application Insights:
Based on application, the global meningitis diagnostic testing market is segmented into hospitals and clinics, diagnostic centers, research centers and academic medical centers. Hospitals and clinics dominated the market in 2017 owing to factors such as increasing number of patients with bacterial meningitis across the globe. According to a study published by WHO in 2016, out of 10 million cases of bacterial meningitis reported every year globally only about 75000 are treated with antibiotics resulting in high under treatment rate for this disease which if addressed could lead to an increase in revenue generation for companies offering products within the industry.
Regional Analysis:
North America dominated the market in 2017 owing to the presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher spending capacity of individuals. The U.S., which is at the forefront, accounted for more than 80% share in North America and is expected to continue its dominance over the forecast period as well.
Asia Pacific is anticipated to register a lucrative growth rate during the forecast period due to rising incidences of meningococcal disease coupled with increasing R&D activities by various organizations in this region. In addition, growing medical tourism industry and improving healthcare facilities are also likely contributors toward regional growth during the same period.
Growth Factors:
- Increasing incidence of meningitis: The global incidence of meningitis is increasing due to various factors such as population growth, increased travel and changing demographics. This is expected to result in an increase in demand for meningitis diagnostic testing products.
- Growing awareness about the disease: There is a growing awareness about the symptoms and risk factors associated with meningitis, which is driving demand for diagnostic tests.
- Technological advancements: The development of new and innovative technologies has led to the introduction of novel diagnostic tests for Menigits which are helping to improve accuracy and speed up diagnosis time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Meningitis Diagnostic Testing Market Research Report
By Type
Latex Agglutination Tests, PCR Assay, Lateral Flow Assay, Culture Test, ELISA Tests
By Application
Hospitals and Clinics, Diagnostic Centers, Research Centers and Academic Medical Centers
By Companies
Thermo Fisher Scientific, Bio-Rad Laboratories, Fast Track Diagnostics, Siemens Healthineers, ELITechGroup, Nanosphere (Luminex Corporation), Seegene, Abbott Laboratories, BioFire Diagnostics, Qnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Meningitis Diagnostic Testing Market Report Segments:
The global Meningitis Diagnostic Testing market is segmented on the basis of:
Types
Latex Agglutination Tests, PCR Assay, Lateral Flow Assay, Culture Test, ELISA Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Centers, Research Centers and Academic Medical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Fast Track Diagnostics
- Siemens Healthineers
- ELITechGroup
- Nanosphere (Luminex Corporation)
- Seegene
- Abbott Laboratories
- BioFire Diagnostics
- Qnostics
Highlights of The Meningitis Diagnostic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Latex Agglutination Tests
- PCR Assay
- Lateral Flow Assay
- Culture Test
- ELISA Tests
- By Application:
- Hospitals and Clinics
- Diagnostic Centers
- Research Centers and Academic Medical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meningitis Diagnostic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meningitis diagnostic testing is a process used to determine the cause of meningitis. This can include tests to look for bacteria, viruses, and other infections. Tests may also be done to rule out other causes of head or neck pain.
Some of the key players operating in the meningitis diagnostic testing market are Thermo Fisher Scientific, Bio-Rad Laboratories, Fast Track Diagnostics, Siemens Healthineers, ELITechGroup, Nanosphere (Luminex Corporation), Seegene, Abbott Laboratories, BioFire Diagnostics, Qnostics.
The meningitis diagnostic testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Meningitis Diagnostic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Meningitis Diagnostic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Meningitis Diagnostic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Meningitis Diagnostic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Meningitis Diagnostic Testing Market Size & Forecast, 2020-2028
4.5.1 Meningitis Diagnostic Testing Market Size and Y-o-Y Growth
4.5.2 Meningitis Diagnostic Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Latex Agglutination Tests
5.2.2 PCR Assay
5.2.3 Lateral Flow Assay
5.2.4 Culture Test
5.2.5 ELISA Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Diagnostic Centers
6.2.3 Research Centers and Academic Medical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Meningitis Diagnostic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Meningitis Diagnostic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Latex Agglutination Tests
9.6.2 PCR Assay
9.6.3 Lateral Flow Assay
9.6.4 Culture Test
9.6.5 ELISA Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Diagnostic Centers
9.10.3 Research Centers and Academic Medical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Latex Agglutination Tests
10.6.2 PCR Assay
10.6.3 Lateral Flow Assay
10.6.4 Culture Test
10.6.5 ELISA Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Diagnostic Centers
10.10.3 Research Centers and Academic Medical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Latex Agglutination Tests
11.6.2 PCR Assay
11.6.3 Lateral Flow Assay
11.6.4 Culture Test
11.6.5 ELISA Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Diagnostic Centers
11.10.3 Research Centers and Academic Medical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Latex Agglutination Tests
12.6.2 PCR Assay
12.6.3 Lateral Flow Assay
12.6.4 Culture Test
12.6.5 ELISA Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Diagnostic Centers
12.10.3 Research Centers and Academic Medical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Latex Agglutination Tests
13.6.2 PCR Assay
13.6.3 Lateral Flow Assay
13.6.4 Culture Test
13.6.5 ELISA Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Diagnostic Centers
13.10.3 Research Centers and Academic Medical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Meningitis Diagnostic Testing Market: Competitive Dashboard
14.2 Global Meningitis Diagnostic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Bio-Rad Laboratories
14.3.3 Fast Track Diagnostics
14.3.4 Siemens Healthineers
14.3.5 ELITechGroup
14.3.6 Nanosphere (Luminex Corporation)
14.3.7 Seegene
14.3.8 Abbott Laboratories
14.3.9 BioFire Diagnostics
14.3.10 Qnostics
